Inge Stalljann - Info zur Person mit Bilder, News & Links



	CML Andrea Poetsch Nicole Schomber Pleil-Lösch

News

Private Homepages

CML Studiengruppe - Kontakt

www.kompetenznetz-leukaemie.de

3 Agu · Inge Stalljann (Studienassistenz) E-Mail: inge.stalljann@ medma.uni-heidelberg.de. Dr. Ute Kossak-Roth (Wiss.Tidak ada: Rödermark" | Harus menyertakan:Rödermark" 3 Agu · Inge Stalljann (Studienassistenz) E-Mail: inge.stalljann@ medma.uni-heidelberg.de. Dr. Ute Kossak-Roth (Wiss. Tidak ada: Rödermark" | Harus menyertakan:Rödermark"

Bücher

HEALTH-RELATED QUALITY OF LIFE IN CML PATIENTS UNDER NILOTINIB

library.ehaweb.org

Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event...

Veröffentlichungen allgemein

Younger patients with chronic myeloid leukemia do well in spite of...

link.springer.com

· ... Nicole Schomber, Andrea Poetsch, Inge Stalljann, and all CML trial participants (see supplemental Appendix in the online article).

Artikel & Meinungen

Safety and efficacy of imatinib in CML over a period of 10 years:...

www.nature.com

Regina Pleil-Lösch, Inge Stalljann, Gabriele Bartsch, Uwe Böhm, Sabine Dean and all participating investigators with their teams for their contributions.

Verwandte Suchanfragen zu Inge Stalljann

Personen
Vorname "Inge" (16183)
Name "Stalljann" (20)

sortiert nach Relevanz / Datum

Erweiterte Suche

Dossier exportieren

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Inge Stalljann Person-Info

News

Private Homepages

CML Studiengruppe - Kontakt

Bücher

HEALTH-RELATED QUALITY OF LIFE IN CML PATIENTS UNDER NILOTINIB

Veröffentlichungen allgemein

Younger patients with chronic myeloid leukemia do well in spite of...

Artikel & Meinungen

Safety and efficacy of imatinib in CML over a period of 10 years:...

Sonstiges

Inge Stalljann (ingestalljann) - Profile | Pinterest

Older patients with chronic myeloid leukemia (≥65 years) profit more...

Younger patients with chronic myeloid leukemia do well in spite of...

[PDF] Deep Molecular Response Is Reached by the Majority of Slaopwww.slaop.org › pdf